Health

Safe and Sufficient Glycemic Control by Using a Digital Clinical Decision Support System for Patients With Type 2 Diabetes in a Routine Setting on General Hospital Wards

Publication from Health
Kompetenzgruppe Klinische Entscheidungsunterstützung

Lichtenegger KM, Aberer F, Tuca AC, Donsa K , Höll B, Schaupp L, Plank J, Beck P, Fruhwald FM, Kamolz LP, Pieber TR, Mader JK

Journal of Diabetes Science and Technology , 3/2021

Abstract:

The aim was to investigate the applicability of a clinical decision support system in a real-world inpatient setting for patients with type 2 diabetes on general hospital wards.A total of 150 patients with type 2 diabetes requiring subcutaneous insulin therapy were treated with basal-bolus insulin therapy guided by a decision support system (GlucoTab) providing automated workflow tasks and suggestions for insulin dosing to health care professionals.By using the system, a mean daily blood glucose (BG) of 159 ± 32 mg/dL was achieved. 68.8% of measurements were in the target range (70 to <180 mg/dL). The percentage of BG values <40, 70, and ≥300 mg/dL was 0.02%, 2.2%, and 2.3%, respectively. Health care professionals' adherence to suggested insulin doses and workflow tasks was high (>93% and 91%, respectively).The decision support system facilitates safe and efficacious inpatient diabetes care by standardizing treatment workflow and providing decision support for basal-bolus insulin dosing.

Keywords: algorithm; decision support; hospital; insulin therapy; mobile applications; type 2 diabetes

Url: https://pubmed.ncbi.nlm.nih.gov/32914640/